Kalaris Therapeutics, Inc. KLRS
Nasdaq · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2020-07-30
Kalaris Therapeutics, Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | 66,151 | $381,691 | 0.29% |
| MILLENNIUM MANAGEMENT LLC | 59,534 | $343,511 | 0.26% |
| TWO SIGMA INVESTMENTS, LP | 30,650 | $176,850 | 0.13% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.